CDI9-CD28 (RO7443904) combination with glofitamab enhances T-cell proliferation and effector function in patients with relapsed/refractory non-Hodgkin lymphoma (R/R NHL) Meeting Abstract
| Authors: | Korfi, K.; Wilson, S.; Jiang, Z.; Christiansen, A.; Krishnan, S.; Jamois, C.; Blank, A.; Epp, A.; Silva, A.; Knuckles, P.; Hayward, J.; Sam, J.; Lechner, K.; Dimier, N.; Caimi, P. F.; Falchi, L.; Gritti, G.; Morschhauser, F.; Hutchings, M.; Dickinson, M. J.; Carlo-Stella, C. |
| Abstract Title: | CDI9-CD28 (RO7443904) combination with glofitamab enhances T-cell proliferation and effector function in patients with relapsed/refractory non-Hodgkin lymphoma (R/R NHL) |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 644 |
| End Page: | 646 |
| Language: | English |
| ACCESSION: | WOS:001412638600044 |
| DOI: | 10.1182/blood-2024-201406 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
